Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Simon A Rule

Allogeneic stem cell transplantation as part of front line therapy for Mantle cell lymphoma

scientific article published on 17 December 2018

Blastoid and pleomorphic mantle cell lymphoma: still a diagnostic and therapeutic challenge!

scientific article published on 01 November 2018

Durable response with single-agent acalabrutinib in patients with relapsed or refractory mantle cell lymphoma

scientific article published on 26 September 2019

Final 5-year findings from the phase 3 HELIOS study of ibrutinib plus bendamustine and rituximab in patients with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma

scientific article published on 06 August 2020

Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study.

scientific article published on 2 February 2018

Incidence of and risk factors for major haemorrhage in patients treated with ibrutinib: An integrated analysis

scientific article published on 02 December 2018

Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial

scientific article

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results

scientific article

Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

scientific article published on 4 April 2017

Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)

scientific article published on 11 December 2019

Outcomes in first relapsed-refractory younger patients with mantle cell lymphoma: results from the MANTLE-FIRST study

scientific article published on 11 August 2020

Postibrutinib outcomes in patients with mantle cell lymphoma

scientific article

Prospective subgroup analyses of the randomized MCL-002 (SPRINT) study: lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma.

scientific article published on 28 November 2017

Receiving treatment at a specialist centre confers an overall survival benefit for patients with mantle cell lymphoma

scientific article published on 26 November 2018

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

scientific article

Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

scientific article published on 12 October 2018

Weekly versus twice weekly bortezomib given in conjunction with rituximab, in patients with recurrent follicular lymphoma, mantle cell lymphoma and Waldenström macroglobulinaemia

scientific article published on 29 September 2010

Paulina is supported by:

About Paulina

Help